2018
DOI: 10.1016/j.niox.2017.11.006
|View full text |Cite
|
Sign up to set email alerts
|

8-Nitro-cGMP is a promoter of osteoclast differentiation induced by RANKL

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 31 publications
1
9
0
Order By: Relevance
“…Confocal microscopy revealed that although B. abortus S19 was located both extracellularly and intracellularly, large numbers of bacteria were observed inside mature osteoclasts at different cellular depths. Osteoclasts are multinucleated boneresorbing cells that differentiate from monocyte/macrophage lineage under the effect of two osteoclastogenic cytokines that are required for their survival and differentiation: receptor activator of nuclear factor B (NF-B) ligand (RANKL) and macrophage colonystimulating factor (MCSF) (55)(56)(57)(58). Osteoclasts degrade bone matrix through secretion of several osteolytic enzymes and acids that solubilize bone components (59,60), and previous studies have reported that activated osteoclasts play a pivotal role in bone destruction, such as an inflammatory bone loss and rheumatoid arthritis (61).…”
Section: Discussionmentioning
confidence: 99%
“…Confocal microscopy revealed that although B. abortus S19 was located both extracellularly and intracellularly, large numbers of bacteria were observed inside mature osteoclasts at different cellular depths. Osteoclasts are multinucleated boneresorbing cells that differentiate from monocyte/macrophage lineage under the effect of two osteoclastogenic cytokines that are required for their survival and differentiation: receptor activator of nuclear factor B (NF-B) ligand (RANKL) and macrophage colonystimulating factor (MCSF) (55)(56)(57)(58). Osteoclasts degrade bone matrix through secretion of several osteolytic enzymes and acids that solubilize bone components (59,60), and previous studies have reported that activated osteoclasts play a pivotal role in bone destruction, such as an inflammatory bone loss and rheumatoid arthritis (61).…”
Section: Discussionmentioning
confidence: 99%
“…iNOS and eNOS are expressed in human PDL stem cells (103,104). Previous studies revealed the presence of sGC and cGMP in mouse bone marrow macrophages ( 105), osteoclasts (105)(106)(107), and osteocytes (108). Davidovitch et al (109,110) performed immunohistochemistry (IHC) on alveolar bone sections obtained from cats and revealed that cGMP expression was increased in the PDL fibroblast cells stained intensely for; however, most cGMP expression was not detected through IHC staining in osteoblasts.…”
Section: Effects Of No On Orthodontic Tooth Movementmentioning
confidence: 99%
“…It has been observed that the promoting effect of iNOS on osteoclasts is mediated through the NO/cGMP pathway. Kaneko et al (105) revealed that 8-nitro-cGMP, a NO-dependent derivative of cGMP in mammals, increased RANKL mRNA expression, and enhanced osteoclast differentiation. The reduction in cGMP levels due to the inhibition of NOS caused RANKL-induced osteoclast differentiation suppression.…”
Section: Osteoclastsmentioning
confidence: 99%
“…8-Nitro-cGMP is involved in a number of cellular phenomena including cardiac cell senescence, neuronal cell death, the antioxidant stress response, chondrocyte proliferation, bone growth, osteoclast differentiation, and stomatal closure. (10,14,32,34,(40)(41)(42)(43) 8-Nitro-cGMP can activate cGMP-dependent protein kinase and stimulate vasorelaxation, similar to the well-known NO second messenger, cGMP. (32) Moreover, 8-nitro-cGMP is active stronger than cGMP under physiological conditions because the nitrated nucleotide is resistant to phosphodiesterase-dependent degradation.…”
Section: Formation Of Electrophilic Redox Signaling Molecules and Thementioning
confidence: 99%